- Home
- NKTX vs EUDA Comparison
NKTX vs EUDA Comparison
Compare NKTX & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- EUDA
- Stock Information
- Founded
- NKTX 2015
- EUDA 2021
- Country
- NKTX United States
- EUDA Singapore
- Employees
- NKTX N/A
- EUDA N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- EUDA Blank Checks
- Sector
- NKTX Health Care
- EUDA Finance
- Exchange
- NKTX Nasdaq
- EUDA Nasdaq
- Market Cap
- NKTX 123.5M
- EUDA 146.0M
- IPO Year
- NKTX 2020
- EUDA N/A
- Fundamental
- Price
- NKTX $1.80
- EUDA $3.21
- Analyst Decision
- NKTX Strong Buy
- EUDA
- Analyst Count
- NKTX 6
- EUDA 0
- Target Price
- NKTX $14.40
- EUDA N/A
- AVG Volume (30 Days)
- NKTX 434.5K
- EUDA 98.7K
- Earning Date
- NKTX 08-12-2025
- EUDA 01-01-0001
- Dividend Yield
- NKTX N/A
- EUDA N/A
- EPS Growth
- NKTX N/A
- EUDA N/A
- EPS
- NKTX N/A
- EUDA N/A
- Revenue
- NKTX N/A
- EUDA $4,011,005.00
- Revenue This Year
- NKTX N/A
- EUDA $212.19
- Revenue Next Year
- NKTX N/A
- EUDA $254.35
- P/E Ratio
- NKTX N/A
- EUDA N/A
- Revenue Growth
- NKTX N/A
- EUDA 8.22
- 52 Week Low
- NKTX $1.31
- EUDA $2.92
- 52 Week High
- NKTX $8.23
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- NKTX 51.45
- EUDA 37.78
- Support Level
- NKTX $1.68
- EUDA $3.15
- Resistance Level
- NKTX $1.84
- EUDA $3.60
- Average True Range (ATR)
- NKTX 0.08
- EUDA 0.14
- MACD
- NKTX 0.01
- EUDA -0.04
- Stochastic Oscillator
- NKTX 80.95
- EUDA 0.46
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.